Tandem Diabetes Care, Inc. (TNDM) Operating margin 2016–2025
Tandem Diabetes Care, Inc. (TNDM) operating margin by fiscal year — reported operating income divided by reported revenue.
-18.5%FY2025 · since FY2016: -92.6% → -18.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -18.5% | -7.9 pp |
| FY2024 | -10.5% | +20.6 pp |
| FY2023 | -31.2% | -19.6 pp |
| FY2022 | -11.6% | -14.8 pp |
| FY2021 | 3.2% | +4.8 pp |
| FY2020 | -1.6% | +3.0 pp |
| FY2019 | -4.6% | +19.7 pp |
| FY2018 | -24.3% | +34.2 pp |
| FY2017 | -58.5% | +34.1 pp |
| FY2016 | -92.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TNDM financial trends
TNDM RevenueTNDM Net incomeTNDM Net marginTNDM Gross profitTNDM Gross marginTNDM Operating incomeTNDM Operating cash flowTNDM Free cash flowTNDM Capital expendituresTNDM Return on equityTNDM Stock buybacksTNDM Dividends paidTNDM Total assetsTNDM Total liabilitiesTNDM Shareholders’ equityTNDM overview →